Skip to content
The GLP-1 Verdict
Menu
Ranked #139 · Grade C

MyDrHank review

A six-shelf prescription telehealth catalogue that publishes its whole GLP-1 term ladder up front — and then advertises only the twelve-month prepay rung, so the price you see is never the price you pay monthly.

Visit MyDrHank Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$259/mo injectable month-to-month, $220/mo on 3 months, $198/mo on 6 months, $178/mo on a 12-mo prepay
Tirzepatide
$349/mo month-to-month, $297/mo on 3 months, $267/mo on 6 months, $240/mo on a 12-mo prepay
Coverage
44 states — excludes Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia
Brand-name
Compounded only

The scorecard

MyDrHank scored on our six published factors. See the methodology.

Real-world results80/100
Price honesty55/100
Prescriber access66/100
Formulary choice86/100
Cancellation fairness52/100
Member support70/100

What we like

  • The complete term ladder is published on the product page before any intake quiz — monthly, quarterly, six-month and yearly, each with its up-front total as well as its per-month rate
  • Both molecules at labelled doses, plus a genuinely uncommon oral semaglutide tablet, so the needle is optional on the semaglutide line
  • The corporate entity is credited: "Dr. Hank, LLC" is named in both the privacy policy and the terms of use
  • No FDA warning letter is on record for MyDrHank, Dr. Hank, LLC or mydrhank.com — checked against FDA's warning-letter database in August 2026
  • The GLP-1 FAQ commits to a flat price across every dose, so titrating up does not raise the bill

The caveats

  • Every price the funnel displays is the twelve-month prepay rate: the price component is a min() over the term ladder, so "From $178/mo" semaglutide really means $2,140 paid up front, and the month-to-month rate is rendered on no page at all
  • One advertised figure exists at no tier — a footnote reads "Plans start at $171/mo for compounded semaglutide and $200/mo for compounded tirzepatide", but no tirzepatide rung is $200 and the $171 belongs to the oral tablet, not the injection
  • The FAQ describes a prepaid twelve-month rate as a plan "with no contract"
  • Oral semaglutide runs a parallel ladder ($249 month-to-month down to $171/mo on a yearly prepay) that the injectable price above does not cover — check which product a quoted figure is for
  • No pharmacy is named anywhere on the site or in its bundle, only "compounded in an FDA-registered U.S. pharmacy", and the consumer pages publish no served-states list at all

The verdict

Best for: Buyers who have already decided to prepay a year and want the full term ladder, with its up-front totals, visible before any intake quiz. A six-shelf prescription telehealth catalogue that publishes its whole GLP-1 term ladder up front — and then advertises only the twelve-month prepay rung, so the price you see is never the price you pay monthly.

Ranked #139 of 507 providers we have reviewed — for comparison, read what CoreAge Rx scores, and why, our #1 pick. On the board it sits between Voxy, 71/100 above and SkinnyRx at 68/100 below, with the altRX ruling the next one down.

MyDrHank is one of 507 rulings on this board, which makes the fair next question who sits above it — our shortlist of MyDrHank alternatives answers it in order, with every score shown. We have also ruled on it directly: CoreAge Rx vs MyDrHank goes to CoreAge Rx, 94/100 to 68/100.

Visit MyDrHank

Compare with other providers

All 506 other providers we've reviewed, in our overall ranking order.

Every other program we track (500)

Pricing, states and verification reflect MyDrHank's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on MyDrHank's site. Not medical advice; see our disclosure.

← Back to all rankings